Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIMBUS: Erythropoietin for Neovascularization in Cerebral Perfusion Deficits
NCT02603406Phase 2Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of erythropoietin in ischemic stroke, Moyamoya disease, Transient Ischemic Attack (TIA), sponsored by Ajou University School of Medicine. Started Jul 2016; status: completed.
02
Drugs
erythropoietin
03
Conditions
ischemic strokeMoyamoya diseaseTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT02603406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603406.